Can an Old Ally Defeat a New Enemy?-Reference-Cited by-同舟云学术

Can an Old Ally Defeat a New Enemy?

Published:2020-07-28 Issue:4 Volume:142 Page:315-317
ISSN:0009-7322
Container-title:Circulation
language:en
Short-container-title:Circulation

Author:

Gurbel Paul A.¹^ORCID,Bliden Kevin P.¹,Schrör Karsten²

Affiliation:

1. Sinai Center for Thrombosis Research and Drug Development, Baltimore, MD (P.A.G., K.P.B.).

2. Department of Pharmacology and Clinical Pharmacology, Heinrich-Heine-University, Düsseldorf, Germany (K.S.).

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Physiology (medical),Cardiology and Cardiovascular Medicine

Reference5 articles.

1. Schrör, K. Acetylsalicylic Acid. 2nd ed. Schrör, KK, ed. Weinheim, Germany: Wiley-VCH Verlag GmbH & Co; 2016.

2. D, L-lysine acetylsalicylate + glycine Impairs Coronavirus Replication

3. Targeting intracellular signaling as an antiviral strategy: aerosolized LASAG for the treatment of influenza in hospitalized patients

4. Gurbel, P, Tantry, US, Tehrani, B, Tran, H, Bliden, K. First study of inhaled versus chewed aspirin: pharmacokinetic and pharmacodynamic effects. Paper presented at: ACC.20/WCC Congress of Cardiology; March 29, 2020; Atlanta, GA. Presentation 1314-151.

5. Dissolution and pharmacokinetics of a novel micronized aspirin formulation

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Aspirin on Clinical Outcomes of COVID-19: A Meta-Analysis;Advances in Clinical Medicine;2024

2. COVID-19 outcomes in patients taking cardioprotective medications;PLOS ONE;2022-10-10

3. Antiplatelet therapy for patients with COVID-19: Systematic review and meta-analysis of observational studies and randomized controlled trials;Frontiers in Medicine;2022-09-07

4. PHARMACOLOGICAL PROTECTION OF VASCULAR ENDOTHELIUM IN ACUTE COVID-19;J PHYSIOL PHARMACOL;2022

5. Premorbid aspirin use is not associated with lower mortality in older inpatients with SARS-CoV-2 pneumonia;GeroScience;2022-01-07